| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On March 24, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1977N-0230
|
| Penicillin-Containing Premixes
|
|
|
|
|
| 1980N-0208
|
| Biological Products; Bacterial Vaccines and Toxiods
|
|
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2004D-0524
|
| Draft Guidance for Industry on ANDAs: Pharmaceutical Solid Polymorphism; Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| 2004P-0329
|
| Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
|
|
|
|
|
| 2005P-0095
|
| ANDA 505(b)(2) application for any generic version or other pharmaceutical alternative of Venofer(Iron sucrose injection USP
|
|
|
|
|
| 2005P-0114
|
| ANDA for Cefriaxone for injection, USP, pharmacy bulk package in a 100 gram dosage strength packaged in plastic bags that are contained within foil outer wraps
|
|
|
|
|
| 2005P-0115
|
| Immediately remove from the market pemoline CYLER- Abbott Laboratories, and all generic versions, a stimulant drug for the treatment of attention deficit hyperactivity disorder.
|
|
|
|
|
| 1977N-0230
|
| Penicillin-Containing Premixes
|
|
|
|
|
| ANS 5
|
| Joseph P, Hile to A. Karim Ahmed, Ph.D.
|
| Vol #:
|
| 24
|
|
|
|
|
| ANS 6
|
| Arthur Hull Hayes Jr. MD
|
| Vol #:
|
| 24
|
|
|
|
|
| ANS 7
|
| Phillip J. Frappaolo
|
| Vol #:
|
| 24
|
|
|
|
|
| 1980N-0208
|
| Biological Products; Bacterial Vaccines and Toxiods
|
|
|
|
|
| C
16
|
| Department of the Army
|
| Vol #:
|
| 142
|
|
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
|
|
| M
740
|
| Statistical Report - Month of January 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
741
|
| Statistical Report - Month of February 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
742
|
| Statistical Report - Month of March 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
743
|
| Statistical Report - Month of April 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
744
|
| Statistical Report - Month of May 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
745
|
| Statistical Report - Month of June 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
746
|
| Statistical Report - Month of July 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
747
|
| Statistical Report - Month of August 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
15698
|
| Lyons Health Products
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15699
|
| Hillestad Pharmaceuticals
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15700
|
| Nature's Way Products, Inc.
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15701
|
| Hillestad Pharmaceutials
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15702
|
| Hillestad Pharmaceuticals
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15703
|
| Hillestad Pharmaceuticals
|
| Vol #:
|
| 138
|
|
|
|
|
| LET
15704
|
| LaneLabs USA, Inc.
|
| Vol #:
|
| 138
|
|
| | | | | | | | |
|
|
|
|
| LET
15705
|
| LaneLabs USA, Inc.
|
| Vol #:
|
| 138
|
|
|
|
|
| 2004D-0524
|
| Draft Guidance for Industry on ANDAs: Pharmaceutical Solid Polymorphism; Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| C
5
|
| GlaxoSmithKline (GSK)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| C
200
|
| Pet Food Institute (PFI)
|
| Vol #:
|
| 23
|
|
|
|
|
| 2004P-0329
|
| Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
|
|
|
|
|
| LET
1
|
| HFZ-001 to Russel J. Thomsen, M.D.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0095
|
| ANDA 505(b)(2) application for any generic version or other pharmaceutical alternative of Venofer(Iron sucrose injection USP
|
|
|
|
|
| LET
1
|
| Luitpold Pharmaceuticals, Inc., (Luitpold)
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0114
|
| ANDA for Cefriaxone for injection, USP, pharmacy bulk package in a 100 gram dosage strength packaged in plastic bags that are contained within foil outer wraps
|
|
|
|
|
| CP
1
|
| Samson Medical Technologies, L.L.C.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0115
|
| Immediately remove from the market pemoline CYLER- Abbott Laboratories, and all generic versions, a stimulant drug for the treatment of attention deficit hyperactivity disorder.
|
|
|
|
|
| ACK
1
|
| HFA-305 to Public Citizen
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Public Citizen
|
| Vol #:
|
| 1
|
|
